Tag: TENDAYI WESTERHOF

There Is Nothing Fishy About ZNNP+ Coordinating MIPA Says Dr Madzima

Michael Gwarisa

NATIONAL AIDS Council Chief Executive Officer (CEO), Dr Benard Madzima has indicated that the Zimbabwe National Network of People Living With HIV (ZNNP+) was the right platform through which the People Living With HIV (PLHIV) sector should be coordinated. By Michael Gwarisa His response comes hot on the heels of a letter that has since gone viral on social media and was penned by HIV activist and National AIDS Council (NAC) board member, Mrs Tendayi Westerhof where she expressed displeasure in the manner the NAC board was granting the ZNNP+…

Read More

“Let’s Not Address Health Issues In Silos During Lockdown”

Michael Gwarisa

THE National AIDS Council (NAC) Chief Executive Officer, Dr Benard Madzima says the new level four lockdown presents an opportunity for Zimbabwe to correct the mistakes of the first lockdown which saw a sizable number of people struggling to access essential healthcare services. By Michael Gwarisa In an interview with HealthTimes, Dr Madzima said even though HIV  is still a burden on the country’s health sector, it was critical to prioritise other issues such as Gender Based Violence (GBV), maternal health, access to contraceptives, Sexual Reproductive Health and Rights (SRHR),…

Read More

Celebrating Tendayi Westerhof @54, A Beacon Of HIV Activism In Zimbabwe

Michael Gwarisa

TODAY, June 22,  2020 marks exactly 54 years since Tendayi Westerhof, a woman who has grown to be a force to reckon in the fight for  the rights of persons living with HIV in Zimbabwe was born in the rural villages of the midlands province. Despite having ascended to fame as a model back in the 90s, Tendayi’s humble rural background has made her tough and unwavering in the things she holds dearly at heart. At one point in 1979 towards the end of the liberation struggle, Tendayi together with…

Read More

DTG Won’t Be Forced On Citizens- Ministry

Michael Gwarisa

PEOPLE Living With HIV (PLHIV) and on Antiretroviral Therapy (ART) still have the option to continue taking other ART options apart from Dolutogravir (DTG) based regimens  since the process is not compulsory, a ministry of health and child care (MoHCC) official has said. By Michael Gwarisa in Gweru Zimbabwe commenced its transition process from Tenovir/Lamuvidene/Efavirens to Dolutegravir (DTG) in May 2019, and the transition procedure will be completed by February 2020. Briefing a women living with HIV, Sexual Reproductive Health and Rights (SRHR) workshop organised by PAPWC/ZIM,  ZWLHNF and UNAIDS,…

Read More